Is the safety of lithium no longer in the balance?

The Lancet

Volumn 379, Issue 9817, 2012, Pages 690-692

  Malhi, Gin S ^a,b,c   Berk, Michael ^d,e,f,g  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c New South Wales Government   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f BARWON HEALTH   (Australia)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; LITHIUM; OLANZAPINE;

AGE; BIPOLAR DISORDER; CALCIUM BLOOD LEVEL; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; HUMAN; HYPOTHYROIDISM; KIDNEY FAILURE; NEPHROTOXICITY; NOTE; PARATHYROID DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RISK BENEFIT ANALYSIS; SIDE EFFECT; TERATOGENICITY; THYROID DISEASE; TREMOR; WEIGHT GAIN;

EID: 84857647199     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61703-0     Document Type: Note

References (15)

1. JR Geddes, GM Goodwin, J Rendell et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial Lancet 375 2010 385 395
2. JW Newcomer Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review CNS Drugs 19 suppl 1 2005 1 93 (Pubitemid 40677047)
3. GS Malhi, D Adams, M Berk Is lithium in a class of its own? A brief profile of its clinical use Aust N Z J Psychiatry 43 2009 1093 1104
4. RF McKnight, M Adida, K Budge, S Stockton, GM Goodwin, JR Geddes Lithium toxicity profile: a systematic review and meta-analysis Lancet 2012 10.1016/S0140-6736(11)61516-X published online Jan 20.
5. J Tredget, A Kirov, G Kirov Effects of chronic lithium treatment on renal function J Affect Disord 126 2010 436 440
6. J Coresh, BC Astor, T Greene, G Eknoyan, AS Levey Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12 (Pubitemid 36043346)
7. F Ng, OK Mammen, I Wilting et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments Bipolar Disord 11 2009 559 595
8. 2+ uptake into platelets in bipolar affective disorder and controls Clin Neuropharmacol 19 1996 48 51
9. GS Malhi, M Tanious Optimal frequency of lithium administration in the treatment of bipolar disorder. Clinical and dosing considerations CNS Drugs 25 2011 1 10
10. WE Severus, IA Lipkovich, RW Licht et al. In search of optimal lithium levels and olanzapine doses in the long-term treatment of bipolar I disorder. A post-hoc analysis of the maintenance study by Tohen et al. 2005 Eur Psychiatry 25 2010 443 449
11. GS Malhi, M Tanious, S Gershon The lithiumeter: a measured approach Bipolar Disord 13 2011 219 226
12. WE Severus, N Kleindienst, G Evoniuk et al. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study J Affect Disord 115 2009 466 470
13. A Coppen, M Abou-Saleh, P Millin et al. Decreasing lithium dosage reduces morbidity and side effects during prophylaxis J Affect Disord 5 1983 353 362 (Pubitemid 14244156)
14. P Vestergaard, I Poulstrup, M Schou Prospective studies on a lithium cohort. Tremor, weight gain, diarrhea, psychological complaints Acta Psychiatr Scand 78 1988 434 441
15. CU Correll, JM Kane, P Manu Obesity and coronary risk in patients treated with second-generation antipsychotics Eur Arch Psychiatry Clin Neurosci 261 2011 417 423